Differentiation of opioid drug effects by hierarchical multi-site phosphorylation

Mol Pharmacol. 2013 Mar;83(3):633-9. doi: 10.1124/mol.112.082875. Epub 2012 Dec 13.

Abstract

Differences in the ability of opioid drugs to promote regulated endocytosis of μ-opioid receptors are related to their tendency to produce drug tolerance and dependence. Here we show that drug-specific differences in receptor internalization are determined by a conserved, 10-residue sequence in the receptor's carboxyl-terminal cytoplasmic tail. Diverse opioids induce receptor phosphorylation at serine (S)375, present in the middle of this sequence, but opioids differ markedly in their ability to drive higher-order phosphorylation on flanking residues [threonine (T)370, T376, and T379]. Multi-phosphorylation is required for the endocytosis-promoting activity of this sequence and occurs both sequentially and hierarchically, with S375 representing the initiating site. Higher-order phosphorylation involving T370, T376, and T379 specifically requires GRK2/3 isoforms, and the same sequence controls opioid receptor internalization in neurons. These results reveal a biochemical mechanism differentiating the endocytic activity of opioid drugs.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / pharmacology*
  • Animals
  • Endocytosis / drug effects
  • G-Protein-Coupled Receptor Kinase 2 / metabolism
  • G-Protein-Coupled Receptor Kinase 3 / metabolism
  • HEK293 Cells
  • Humans
  • Mice
  • Neurons / drug effects
  • Neurons / metabolism
  • Phosphorylation
  • Protein Isoforms / metabolism
  • Receptors, Opioid / metabolism*
  • Serine / metabolism
  • Threonine / metabolism

Substances

  • Analgesics, Opioid
  • Protein Isoforms
  • Receptors, Opioid
  • Threonine
  • Serine
  • G-Protein-Coupled Receptor Kinase 3
  • GRK2 protein, human
  • GRK3 protein, human
  • G-Protein-Coupled Receptor Kinase 2